Adcetris is administered through intravenous infusion, or a solution containing the medication that is administered into a vein by a needle. The infusion occurs over a thirty minute time period every three weeks. A patient may have up to 16 cycles of Adcetris treatment in hopes of curing Hodgkin’s disease. As a serious drug, Adcetris has life threatening side effects that an individual may experience within 24 hours of the initial infusion.
Signs of reaction to Adcetris include:
Chest pain or tightness
Side effects of Adcetris include, but are not limited to:
A change in mental state,
An inability to speak or see
Increases the risk of serious viral infection of the brain
Fever chills, weakness, tightness
Quickening or slowing of heart rates
Nausea and Vomiting
Life Threatening Disabilities due to taking Adcetris:
PML – Progressive Multifocal Leukoencephalopathy
Peripheral Sensory Neuropathy
If you or a loved one experiences any of the above-listed side effects from Adcetris, please consult a physician immediately to prevent a worsening of symptoms. Because of such serious side effects, Adcetris was reevaluated by the U.S. Food and Drug Administration (FDA) who suggested caution when using Adcetris. Seattle Genetics manufacturing updated information as of January 2012 on the box labels, including warning and caution labels, contraindication, and dosage & administration. Patients and physicians should be warned about the potential serious side effects prior to using Adcetris.
The attorneys at Alvandi Law Group advocate for those who have been wrongfully harmed from the unexpected side effect of Adcetris – due to the improperly labeled safety labels and precautions. Call a Personal Injury and Pharmaceutical Attorney today for a free consultation pertaining to the facts of individual cases, and let a professional’s experience help you. For legal advice with no obligation, call at (800) 980-6905.